Fractalkine in vascular biology: from basic research to clinical disease
about
sameAs
Melanoma-restricted genesMetabolic Effects of CX3CR1 Deficiency in Diet-Induced Obese MiceIntegrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant miceMonitoring of blood vessels and tissues by a population of monocytes with patrolling behaviorSyk regulates multiple signaling pathways leading to CX3CL1 chemotaxis in macrophages.Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiationThe chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.Distinctive expression of chemokines and transforming growth factor-beta signaling in human arterial endothelium during atherosclerosisDifferential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility.Recruitment of CD8(+) T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1(+) in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profilingSearch for an association between V249I and T280M CX3CR1 genetic polymorphisms, endothelial injury and preeclampsia: the ECLAXIR studyGenetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans.High Glucose Level Disturbs the Resveratrol-Evoked Curtailment of CX3CL1/CX3CR1 Signaling in Human Placental CirculationGene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addictionModulation of syndecan-1 shedding after hemorrhagic shock and resuscitation.Fractalkine expression induces endothelial progenitor cell lysis by natural killer cells.Fractalkine/CX3CL1: a potential new target for inflammatory diseasesA specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patientsTumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression.Effects on serum fractalkine by diet and omega-3 fatty acid intervention: relation to clinical outcome.Fractalkine is a novel human adipochemokine associated with type 2 diabetesPlacental fractalkine is up-regulated in severe early-onset preeclampsia.Aspirin Action in Endothelial Cells: Different Patterns of Response Between Chemokine CX3CL1/CX3CR1 and TNF-α/TNFR1 Signaling Pathways.Pathological role of fractalkine/CX3CL1 in rheumatic diseases: a unique chemokine with multiple functions.Tolerance and lymphoid organ structure and function.High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage.T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients.Stem cells decreased neuronal cell death after hypoxic stress in primary fetal rat neurons in vitro.Thematic review series: the immune system and atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis.Role of chemokines in tumor growth.Molecular mechanisms of cell recruitment to inflammatory sites: general and tissue-specific pathways.Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease.Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interactionFractalkine neutralization improves cardiac function after myocardial infarction.Inflammation: a way to understanding the evolution of portal hypertension.Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in miceFractalkine (CX3CL1) and its receptor CX3CR1 may contribute to increased angiogenesis in diabetic placentaFractalkine restores the decreased expression of StAR and progesterone in granulosa cells from patients with polycystic ovary syndrome
P2860
Q24793788-D4666DD4-1B07-4DAC-AE3F-60A166BD0C48Q27317248-D4E26081-B046-4A12-80FA-523D753B70C8Q28119172-3FD2DB1D-BFF8-46A0-B193-B25521241E95Q28590362-BA2201C6-40CB-488E-8400-14D5B08CEC0FQ29616447-55096FB1-DD73-4461-90A7-BE5A56817D4FQ30427232-84214A06-EA88-4B09-B711-9FAD07D10CACQ30433016-CBA4BBF9-14A7-40B6-9FA1-9766588A20E9Q31160040-75ED20EF-DBE1-4F01-80EE-05C779113380Q33288811-8574079B-BAB4-46C9-B1DD-A07B2021E8B9Q33410786-0E5256E5-856B-4452-842D-AB4319B9D7BCQ33424130-85C7B7F8-DA17-48EA-ACAC-590FFD3D41D2Q33427340-D2E5E009-366E-4FC7-99B0-AEC1C207DB69Q33479988-EB5B676D-8A57-4302-AA11-4E78D4CDC616Q33685670-5183701C-CDB7-4536-AD46-503C4F7A41D0Q33800749-71FB06E9-8B96-45E3-B5E6-C9633EF24671Q33914077-84AFA598-2529-4984-AB5F-7730E695B46AQ34008848-1C22A4BC-5328-4A43-B975-0429A929D045Q34062549-F3E15BF4-F01D-4D11-B646-4886B86CD4FEQ34407627-5152D63D-7B84-45CE-B266-DEFDB0F2D0BCQ34714685-12515CE7-A84C-422D-B0D4-6ACA70206790Q35098062-63A2FAD7-4B1A-40BB-AE3C-6DB0054EB403Q35103027-C2EC5ECF-ABFA-4C4F-938B-DFAECDBB70A4Q35796996-F152D5FB-279B-4947-B3F9-4935A4F9B97DQ35802535-03C61D28-52B8-4D18-992F-C25D80D7AC81Q35907998-57E76EF2-CEF1-4685-8996-2869EFF20CA9Q35927383-A665EAF2-6B71-4E47-9030-8DD6DD5FDB0BQ35927529-3AD28211-D7BD-4F6D-8FA8-BD4B0142C16AQ35990663-937B7494-8708-4A50-9F97-B0E80DA784BBQ36040487-D4F0424E-1826-41C8-8151-80EBE5EC7018Q36072710-2C5B7A5D-A671-446E-8324-81773333DAF7Q36072740-B49CEA47-4549-49FA-AC04-A85C34DED5F9Q36120825-EE85EC00-A19E-43FA-93F9-DE286EB139C9Q36327429-EE147F77-6F1A-4917-8579-650350552613Q36372735-8DC780B8-A4C2-4FD0-8CA4-2EB5FFF145CBQ36384581-BAACCE31-B7FD-45E4-80A1-53A69C328057Q36390463-CBA5AB77-1BDD-4CB6-9A9C-ADAC637F598DQ36391634-D73B3521-8544-4A3C-83D7-1C74CAD8FEF3Q36533785-5DFC8680-4A52-41F0-92C7-9754A26AA940Q37061311-CF91D1E0-4A4F-4925-90AE-48A2ADFADD7FQ37076543-8AC52E42-EE91-4EC8-B4FE-493AFF2A8C68
P2860
Fractalkine in vascular biology: from basic research to clinical disease
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Fractalkine in vascular biology: from basic research to clinical disease
@ast
Fractalkine in vascular biology: from basic research to clinical disease
@en
Fractalkine in vascular biology: from basic research to clinical disease
@nl
type
label
Fractalkine in vascular biology: from basic research to clinical disease
@ast
Fractalkine in vascular biology: from basic research to clinical disease
@en
Fractalkine in vascular biology: from basic research to clinical disease
@nl
prefLabel
Fractalkine in vascular biology: from basic research to clinical disease
@ast
Fractalkine in vascular biology: from basic research to clinical disease
@en
Fractalkine in vascular biology: from basic research to clinical disease
@nl
P2093
P3181
P1476
Fractalkine in vascular biology: from basic research to clinical disease
@en
P2093
Eda T Bloom
Hisanori Umehara
Osamu Yoshie
Toshio Imai
Toshiro Okazaki
Yutaka Nagano
P3181
P356
10.1161/01.ATV.0000095360.62479.1F
P407
P577
2004-01-01T00:00:00Z